All Stories

  1. Fenofibrate Use Is Associated With Lower Mortality and Fewer Cardiovascular Events in Patients With Diabetes: Results of 10,114 Patients From the Korean National Health Insurance Service Cohort

    Article • Diabetes Care, June 2021, American Diabetes Association

    Sang-Ho Jo

  2. Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, doubl...

    Article • Drug Design Development and Therapy, November 2016, Dove Medical Press

    Sang-Ho Jo